期刊
JOURNAL OF SURGICAL ONCOLOGY
卷 101, 期 4, 页码 334-343出版社
WILEY
DOI: 10.1002/jso.21482
关键词
ovarian cancer; neoadjuvant chemotherapy
The current management of advanced ovarian cancer consists of aggressive primary cytoreductive surgery (PCS) followed by combination platinum based chemotherapy. Recent studies have suggested that platinum-based chemotherapy may be of benefit in patients with advanced ovarian cancer prior to cytoreductive surgery (neoadjuvant chemotherapy, NACT). The concept of NACT has not been completely validated in the treatment of ovarian cancer. This review will discuss the role of NACT in patients with advanced epithelial ovarian cancer. J. Surg. Oncol. 2010;101:334-343. (C) 2010 Wiley-Liss, Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据